Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 27, 2003

View Archived Issues

Novel series of HIV protease inhibitors described in recent patent

Two series of IgE antibody production inhibitors identified by Kowa scientists

Tularik presents novel modulators of UPC3 with utility in obesity and diabetes

Spanish team presents novel COX-2 inhibitors in recent patent

Label for Botox widened in Europe

Xenova reports progress in 2002

CV Therapeutics presents novel adenosine A2B antagonists

Ube scientists identify novel series of leukotriene receptor antagonists

Novel alpha2- and/or alpha3-selective GABA-A receptor modulators covered by Merck patent

New PAI-1 inhibitors in early development at Tanabe Seiyaku

Organix and Virginia Commonwealth U. describe novel CB1 modulators

Eisai establishes neuroscience drug discovery research program at Kyoto University

MorphoSys and Boehringer Ingelheim collaborate on therapeutic antibodies

Manhattan Pharmaceuticals and Atlantic Technology Ventures complete merger

Metvix PDT recommended for approval in Australia

Organon and Ligand to copromote Avinza in U.S.

EMEA accepts bortezomib MAA for review

Approval sought for once-daily Reminyl

Nuvelo reveals alfimeprase program progress in 2002

Dukoral approved in Canada

Abilify sNDA submitted for long-term treatment of schizophrenia

Candidacidal alpha-MSH peptide analogues discovered at Zengen

Orphan medicinal product designation for Corixa's Bexxar product

Dendreon to acquire Corvas

New series of GH secretagogues designed by European research team

Binding kinetics and cardioprotective effects of sabiporide characterized

Antiangiogenic activity of FYK-1388 demonstrated in vitro and in vivo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...